Dr. Mathew Thomas is a cardiothoracic surgeon and the Director of Thoracic Surgery and Chair of Robotic Surgery at the Mayo Clinic in Jacksonville, Florida. His primary interest lies in improving and advancing the use of minimally invasive surgical techniques for the treatment of chest malignancies, including lung cancer and malignant pleural mesothelioma. Education and
Dr. Dennis Wigle is a thoracic surgeon and researcher at the Mayo Clinic in Rochester, Minnesota. As Chief of the Division of Thoracic Surgery, his focus is on understanding and treating lung cancer, esophageal cancer, and other thoracic malignancies, including pleural mesothelioma. Education and Career Dr. Wigle is certified in General Surgery and Thoracic Surgery by
For asbestos-exposed individuals, the specter of mesothelioma is always lurking in the background. Every cough or discomfort raises alarm bells that it could be the first sign of a deadly diagnosis. Researchers have been exploring the utility of a screening breath test to help allay these fears and provide an early detection tool. They reported on their
Dr. Giuseppe Giaccone is a hematologist and oncologist at Weill Cornell Medicine, seeing patients at NewYork-Presbyterian Hospital. He ranks among the world’s most highly respected practitioners in the treatment and study of lung cancer and in developmental therapeutics. In addition to his groundbreaking work in early clinical research, he is an expert in the biology
Back in 2009, the International Association for the Study of Lung Cancer presented a model they’d developed to help stage malignant mesothelioma cases. Since then, additional data has been added to the model’s database to continue enhancing its accuracy. This week, the group’s members attending its annual conference in Singapore learned that the model is
Dr. Stephen Liu is a hematologist and oncologist at MedStar Georgetown University Hospital. He focuses on thoracic malignancies, including lung cancer, thymic malignancies, and pleural mesothelioma. He has significant expertise in the development of novel therapeutic agents and in combining treatment protocols with the goal of improving patient outcomes. Education and Career Dr. Liu graduated
Dr. Frank Detterbeck is a thoracic surgeon, board-certified in general surgery as well as in thoracic and cardiac surgery. As a surgeon at the Yale Cancer Center, he has earned a national reputation for performing minimally invasive surgeries for the treatment of lung cancer, mesothelioma, and other thoracic malignancies. Education and Career Dr. Detterbeck earned
Dr. Roy Herbst is an internationally recognized clinician-scientist who has dedicated himself to thoracic cancer treatment and research. He is a leader in the treatment of lung cancer and is renowned for his work in developmental therapeutics and personalized therapies that link the individual patient’s genetic profile to the treatment offered. Education and Career Dr.
Identifying the right treatment plan is one of the many challenges faced by mesothelioma patients and their physicians. Those whose tumors are operable need to decide whether to pursue an aggressive form of surgery that removes the affected lung or to go with a less invasive procedure. A report issued today suggests that those who
Dr. John D. Mitchell is the Chief of General Thoracic Surgery within the Division of Cardiothoracic Surgery at the University of Colorado and the CU Cancer Center. He has extensive experience in treating thoracic cancers, including pleural mesothelioma. His practice specialties include all areas of thoracic oncology and surgery of the airway, with a special